Cite
HARVARD Citation
Boye, K. et al. (2022). IDF21-0018 Patient Reported Outcomes for Tirzepatide versus Semaglutide in Participants with T2D from the SURPASS-2 Trial. Diabetes research and clinical practice. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Boye, K. et al. (2022). IDF21-0018 Patient Reported Outcomes for Tirzepatide versus Semaglutide in Participants with T2D from the SURPASS-2 Trial. Diabetes research and clinical practice. p. . [Online].